Compare Delivra Health Brands, Inc. with Similar Stocks
Stock DNA
Other Agricultural Products
CAD 6 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.25
-12.53%
1.56
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Dec 2025)
Net Profit:
0 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-40.43%
0%
-40.43%
6 Months
-30.0%
0%
-30.0%
1 Year
-12.5%
0%
-12.5%
2 Years
-53.33%
0%
-53.33%
3 Years
460.0%
0%
460.0%
4 Years
180.0%
0%
180.0%
5 Years
12.0%
0%
12.0%
Delivra Health Brands, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.92%
EBIT Growth (5y)
14.71%
EBIT to Interest (avg)
-5.40
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
1.99
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.56
EV to EBIT
-4.97
EV to EBITDA
4.97
EV to Capital Employed
1.76
EV to Sales
0.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.26%
ROE (Latest)
-12.53%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Sep 2020
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.02%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
2.40
3.20
-25.00%
Operating Profit (PBDIT) excl Other Income
-0.40
0.00
Interest
0.10
0.10
Exceptional Items
0.10
0.00
Consolidate Net Profit
-0.40
-0.10
-300.00%
Operating Profit Margin (Excl OI)
-185.00%
-6.90%
-17.81%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -25.00% vs -27.27% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -300.00% vs -120.00% in Sep 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
13.40
12.40
8.06%
Operating Profit (PBDIT) excl Other Income
0.40
0.60
-33.33%
Interest
0.10
0.20
-50.00%
Exceptional Items
-0.10
1.90
-105.26%
Consolidate Net Profit
-1.20
0.90
-233.33%
Operating Profit Margin (Excl OI)
-62.90%
-57.40%
-0.55%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 8.06% vs 26.53% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is -233.33% vs 550.00% in Jun 2024
About Delivra Health Brands, Inc. 
Delivra Health Brands, Inc.
Other Agricultural Products
Harvest One Cannabis Inc.(Harvest One) is a Canada-based company that develops and distributes health, wellness and selfcare products with a market focus on sleep, pain, and anxiety. The Company's subsidiaries include Satipharm Limited (Satipharm), Dream Water Global, and Delivra Corp. (Delivra). Satipharm is a health & wellbeing company, which is specialized in the development and manufacture of cannabinoid-based products from the cannabis plant. Dream Water Global is engaged in selling natural, 0-calorie, liquid sleep shot. Delivra manufactures and sells a line of natural topical creams with the transdermal delivery system platform under the LivRelief brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance.
Company Coordinates 
Company Details
Suite 404, 999 Canada Place , VANCOUVER BC : V6C 3E2
Registrar Details






